Plus Therapeutics Inc (NASDAQ:PSTV)

0.5087
BATS BZX Real-Time Price
As of 3:47pm ET
 -0.002 / -0.39%
Today’s Change
0.39
Today|||52-Week Range
2.32
-51.55%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Plus Therapeutics Inc have a median target of 3.50, with a high estimate of 5.00 and a low estimate of 2.00. The median estimate represents a +588.03% increase from the last price of 0.51.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in Plus Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.22
Sales
$0.00
Reporting Date
Nov 17

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 10.42%
 
 
 
 
 
 
Growthannually 23.42%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.